Wordt geladen...
Targeting Mutant BRAF in Melanoma: Current Status and Future Development of Combination Therapy Strategies
The discovery of activating BRAF mutations in ~50% of all melanomas has proved to be a turning point in the therapeutic management of the disseminated disease. In this commentary we review the latest research delineating the role of mutant BRAF in melanoma initiation and progression and discuss the...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3314865/ https://ncbi.nlm.nih.gov/pubmed/22453012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31824b436e |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|